Jpmorgan Chase & Co »

Prime Medicine shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Prime Medicine (PRME) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Prime Medicine

Tip: Access up to 7 years of quarterly data

All positions including Prime Medicine held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prime Medicine by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $295k 42k 7.00
2023-12-31 $403k 46k 8.86
2023-09-30 $258k 27k 9.54
2023-06-30 $449k 31k 14.65
2023-03-31 $159k 13k 12.33
2022-12-31 $184k 9.9k 18.65